Connect with us
  • tg

Stock Markets

The Canadian Association of Optometrists Releases a New GetEyeWise Digital Campaign to Bring Awareness About Eye Health and Vision Care

letizo News

Published

on

During May Vision Health Month, all Canadians are encouraged to integrate regular eye exams into their healthcare routine and visit their optometrist.

OTTAWA, Ontario–(BUSINESS WIRE)–As May marks Vision Health Month, the Canadian Association of Optometrists (CAO) releases a digital national campaign to raise public awareness about eye health and vision care, encouraging Canadians to get their eyes checked. Several provincial associations of optometrists (New Brunswick (NYSE:) Association of Optometrists, Newfoundland & Labrador Association of Optometrists, Nova Scotia Association of Optometrists, and The Prince Edward Island Association of Optometrists) and sponsors from the industry – Alcon (NYSE:), CooperVision, and Sun Pharma – joined and supported this campaign.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240501239056/en/

Urgent need for public education about eye health and vision care

8+ million Canadians are at risk of eye-threatening conditions, yet 75% of vision loss can be treated or prevented if diagnosed early. Despite Canadians highly valuing their eyesight and fearing its loss, there is a prevalent lack of awareness regarding the necessity of regular, comprehensive eye exams. Many individuals often overlook the importance of thorough examinations for early detection.

A 2022 survey1 revealed a telling statistic: 37% of respondents who had not seen an eye care professional in over two years did so because they believed there was nothing wrong with their vision. Additionally, the survey found that men in Canada are less likely than women to prioritize eye health.

With those statistics in mind, the CAO released a new digital campaign to raise public awareness about eye health and vision through a simple yet potent message: GetEyeWise!

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.

Many serious eye conditions do not present obvious symptoms initially. Waiting for symptoms to appear can expose individuals to significant risks, particularly within an aging population, those engaging in increased near-work, and amidst a myopia epidemic among children. Integrating eye care into the healthcare routines of all age groups, from toddlers to seniors, is crucial, says Dr. Martin Spiro, President of the Canadian Association of Optometrists.

Think of an eye exam as a physical for your eyes¦and more

A comprehensive eye examination is the best tool for the early detection of eye disease and several systemic diseases. It is based on the premise that structural change in the eye (often at the microscopic level) manifests itself well before any functional changes and vision loss occur.

Optometrists diagnose, treat, and help prevent diseases and disorders affecting the visual system (the eye and related structures).

They also assist in identifying general health conditions like stroke, cardiovascular diseases, diabetes, hypertension, some cancers, brain injuries, and neurological conditions that are often first detected through a comprehensive eye exam. They provide referrals to specialists and can help manage post-eye-surgery health. From infants to seniors, optometrists provide care to help maintain good vision, eye health and quality of life.

The Canadian Association of Optometrists developed evidence-based guidelines for Recommended Frequency of the Comprehensive Eye Examination and calls on all Canadians to GetEyeWise.

If grownups think their eyes are fine¦then why are they always doing things like this?

The national campaign features children mimicking adults’ faces in daily situations to encourage everyone to GetEyeWise and book an appointment with an optometrist. It will run throughout May on Facebook (NASDAQ:), Instagram, YouTube, TikTok, and Spotify (NYSE:) in both official languages.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.

Together with the Canadian Association of Optometrists, we are dedicated to raising awareness of the importance of regular eye exams and to helping people see brilliantly, said Vanessa Johari Hansen, Country Business Unit Head, Vision Care, at Alcon Canada. Too often, eye exams are neglected, but through our partnership, we’re determined to enhance vision and improve eye health, recognizing their vital role in overall well-being.”

To find more about the CAO campaign, please visit: https://opto.ca/geteyewise

About the Canadian Association of Optometrists

The Canadian Association of Optometrists (CAO) is the national voice of optometry and is dedicated to providing leadership and support to its 8,300+ members to enhance the delivery of healthy eyes and clear vision for all Canadians. For more information, visit www.opto.ca

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.ca

About CooperVision

CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit https://coopervision.ca

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.

About Sun Pharma

Sun Pharma entered the Canadian market in 2015 with the purchase of Ranbaxy Laboratories Limited, a Top 10 generic company in Canada since 2005. Sun Pharma is a world leader in branded and generic drugs and we are now well positioned to be an even larger contributor to the Canadian healthcare landscape.

With global manufacturing across six continents, we are investing in Canada by bringing high quality, affordable and innovative medicines to market. Our global strength in R&D with an unwavering commitment to quality ensures Sun Pharma will offer a wide range of affordable medicines for Canadians.

Taro Pharmaceuticals is the exclusive distributor of our specialty and generic products in Canada.

We feel the strength of our global Sun Pharma capabilities together with Taro Pharmaceutical’s 30-year commitment to Canadian manufacturing and distribution creates a unique pharmaceutical partner for our Canadian customers. It is our continued goal to provide our customers and partners with high quality products and exceptional customer service.

We look forward to many more years of providing Canadians with high quality and affordable medicines. To learn more, visit: https://sunpharma.com/canada-branded-products/

______
1 Online survey of 2003 Canadians aged 18+ was completed between June 10 and June 21, 2022, using Leger’s online panel conducted on behalf of the Canadian Ophthalmological Society and the Canadian Association of Optometrists.

For media inquiries, please contact:
Julie Vanghelder, Director, Communications & Marketing, jvanghelder@opto.ca

Source: Canadian Association of Optometrists

Stock Markets

US stocks slightly lower after Christmas holiday

letizo News

Published

on

Investing.com– U.S. stocks were slightly lower on Thursday, though trading volumes were thin a day after the Christmas holiday.  

At of 12:58 ET (17:58 GMT), the  fell 0.10%, the was down 0.1%, while the declined 0.01% or 6 points.

Jobless claims in U.S. dip to one-month low

The weekly U.S. jobless claims data released before the market opened on Thursday and saw a one-month low dip. 

The Labor Department reported a decrease of 1,000 in initial applications for state unemployment benefits, bringing the seasonally adjusted figure to 219,000 for the week that ended on December 21. This figure is lower than the 224,000 claims that economists had predicted for the same week.

Meanwhile, the number of individuals receiving benefits after their first week of aid, which serves as an indication of hiring, increased by 46,000. This brought the seasonally adjusted total to 1.910 million for the week that ended on December 14, the highest since November 2021. Economists had previously anticipated the number of these continued claims to be 1.880 million. 

“We do not think that this week’s data will move the needle for any of them, but more prints in line with the tone of this week’s data may motivate the doves on the Committee to speak up,” Jefferies said in a recent note.

Tech stocks flat despite Apple upgrade   

The major tech giants were mostly down after the markets opened, with Apple marginally higher despite an upgrade from tech-bull Wedbush. 

Apple Inc (NASDAQ:) gained 0.2% affter Wedbush raised its price target on Apple to $325 from $300 banking on transformative AI-driven iPhone upgrade cycle poised to fuel growth into 2025. 

“We believe Apple is heading into a multi-year AI driven iPhone upgrade cycle that is still being underestimated by the Street,” Wedbush said in a recent note.

Crypto-related stocks slip as bitcoin skids, but KULR Technology surges on BTC purchase 

Crypto-related stocks including MicroStrategy Incorporated (NASDAQ:), Coinbase Global Inc (NASDAQ:), and Riot Platforms (NASDAQ:) followed bitcoin lower as the most valuable cryptocurrency fell more than 2%. 

KULR Technology jumped 30% after the space technology company bought about 217 bitcoin and detailed plans to allocate up to 90% of its excess cash to bitcoin.

Continue Reading

Stock Markets

Lichen China Limited announces $2.8 million share sale

letizo News

Published

on

XIAMEN, China – Lichen China Limited (NASDAQ:LICN), a company specializing in financial and taxation services, has announced a definitive agreement with several investors for a registered direct offering. The offering involves the sale of 20 million Class A ordinary shares, or pre-funded warrants as an alternative, at a price of $0.14 per share. This transaction is expected to yield approximately $2.8 million in gross proceeds for the company. The offering comes as the company maintains strong financial fundamentals, with InvestingPro data showing an impressive gross profit margin of 61% and a healthy current ratio of 17.55x.

The closing of the sale is anticipated on or about December 27, 2024, pending the fulfillment of customary conditions. Univest Securities, LLC is the sole placement agent for the offering, which is being conducted under an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective on March 1, 2024.

Investors can access the final prospectus supplement and accompanying prospectus, detailing the offering’s terms, on the SEC’s website once filed. The offering is only valid in jurisdictions where it is lawful, and the securities cannot be sold in any jurisdiction where such an offer, solicitation, or sale would be illegal prior to registration or qualification under the applicable securities laws.

Lichen China, with over 18 years of experience, has established a reputation for providing professional and high-quality financial and taxation solutions in China. The company also offers education support services and software and maintenance services under the “Lichen” brand. Despite the stock’s significant decline of 89% year-to-date, InvestingPro analysis indicates the company is currently undervalued, with robust revenue growth of 25% in the last twelve months. Get access to 16 additional ProTips and comprehensive financial analysis with an InvestingPro subscription.

The company’s press release contains forward-looking statements that involve risks and uncertainties. While Lichen China believes the expectations reflected in these statements are reasonable, they caution that actual results may differ materially. Trading at a P/E ratio of 6.4x and with a market capitalization of $8.17 million, investors are encouraged to review factors that may affect the company’s future results in its registration statement and other SEC filings.

This news article is based on a press release statement from Lichen China Limited.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Continue Reading

Stock Markets

2024 Year-End NAIC Designations  for STACR REMIC Trust, STACR Trust, and STACR Debt Notes

letizo News

Published

on

MCLEAN, Va., Dec. 26, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: OTC:) today published on its website the National Association of Insurance Commissioners (NAIC) 2024 filing year designations for certain STACR REMIC Trust, STACR Trust, and STACR Debt Notes (collectively, STACR Notes).

Overall, of the 209 reviewed STACR Notes, all have achieved NAIC 1 Designation including all A1, M1 and M2 Notes offered through 2024 STACR transactions. In addition, 10 of the 2024 NAIC 1 Designations are upgrades from their 2023 NAIC 2 Designations. The below table details the upgrades:

CUSIPDeal Name2023 Year-End NAIC Designation2023 Year-End NAIC Designation Modifier2024 Year-End NAIC Designation2024 Year-End NAIC Designation Modifier
35564KB57STACR 2022-HQA2 M2B2B1E
35564KB65STACR 2022-HQA2 M22A1D
35564KE62STACR 2022-HQA3 M2B2C1F
35564KE70STACR 2022-HQA3 M22B1E
35564KP60STACR 2023-DNA1 M2B2C1E
35564KP94STACR 2023-DNA1 M22A1E
35564KT82STACR 2023-DNA2 M2B2C1E
35564KU31STACR 2023-DNA2 M22A1E
35564KY29STACR 2023-HQA1 M2B2B1E
35564KY37STACR 2023-HQA1 M22A1E

About Freddie Mac Single-Family Credit Risk Transfer

Freddie Mac’s Investment & Capital Markets Credit Risk Transfer (CRT) programs transfer credit risk away from U.S. taxpayers to global private capital via securities and (re)insurance policies, providing stability, liquidity and affordability to the U.S. housing market. The GSE Single-Family CRT market was founded when Freddie Mac issued the first STACR ® (Structured Agency Credit Risk) notes in July 2013. In November 2013, ACIS ® (Agency Credit Insurance Structure ®) was introduced. Today, the industry-leading and award-winning programs attract institutional investors and (re)insurance companies worldwide. For specific STACR and ACIS transaction data, visit Clarity Data Intelligence ®.

About Freddie Mac
Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability, affordability and equity in the housing market throughout all economic cycles. Since 1970, we have helped tens of millions of families buy, rent or keep their home. Learn More: Website | Consumers | LinkedIn | Facebook| X | Instagram | YouTube

MEDIA CONTACT:
Fred Solomon
703-903-3861
Frederick_Solomon@FreddieMac.com

INVESTOR CONTACT:
Christian Valencia
571-382-4236

Source: Freddie Mac

Continue Reading

Trending

©2021-2024 Letizo All Rights Reserved